<DOC>
	<DOCNO>NCT01527188</DOCNO>
	<brief_summary>The purpose study assess effect 3 dos sublingual house dust mite ( HDM ) tablets versus placebo change baseline rhinitis total symptom score allergen chamber challenge 6 month treatment .</brief_summary>
	<brief_title>Efficacy Safety 100IR , 300IR , 500IR Sublingual House Dust Mite ( HDM ) Tablets Allergic Rhinitis Environment Exposure Chamber Model</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>history HDM rhinitis allergy &gt; 1 year sensitize D. pteronyssinus and/or D. farinae RTSS &gt; = 6 least 2 time point allergen challenge session co sensitization allergen HDM FEV1 &lt; 80 % Asthma GINA &gt; 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>HDM</keyword>
	<keyword>allergic rhinitis</keyword>
</DOC>